The contract, Mr. Custer wrote, helped ensure that “veterans have access to clinical trials, with notable efforts directed toward advancing precision prostate cancer screening.” ...

Penpulimab-kcqx, a humanized immunoglobulin G1 monoclonal antibody, blocks the interaction between the programmed death 1 receptor on T-cells and programmed death ligand 1 and 2 on tumor cells.

Additionally, the effectiveness of single-agent penpulimab-kcqx was determined in Study AK105-202. The study included 125 patients with unresectable or metastatic non-keratinizing NPC who had disease ...

Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer, where the endemic subtype is strongly associated with Epstein-Barr virus (EBV) infection, whereas emerging data suggest that a subset ...

Researchers conducted the randomized phase 3 DIPPER trial at 11 centers in China, enrolling 450 patients with T4N1M0 or T1-4N2-3M0 nasopharyngeal carcinoma who had completed induction-concurrent ...

The study included 1,040 patients with nonmetastatic nasopharyngeal carcinoma who received intensity-modulated radiotherapy at Fujian Cancer Hospital between January 2017 and December 2019.

Meta-analysis links high-risk Epstein-Barr virus lineage to nasopharyngeal cancer in southern China. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2024 / 11 ...

Nasopharyngeal cancer is staged from Stage 0 (the earliest stage) to Stage IV (the most advanced stage). The lower the number, the less the cancer has spread to other parts of the body.

Omitting radiation to the lower-neck region in patients with early-stage nasopharyngeal cancer provided similar survival outcomes and reduced long-term toxicity compared to whole-neck irradiation.

Nasopharyngeal carcinoma (NPC) is a rare type of head and neck cancer. Learn about the symptoms, causes, diagnosis, treatment, and outlook here.

Nasopharyngeal cancer is a rare type of head and neck cancer. Learn its symptoms, risk factors, diagnosis methods, treatment options, and prognosis.